Official ESCRS | European Society of Cataract & Refractive Surgeons
Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Visual performance and subjective experience of patients implanted with SBL 3 one year post-implantation

Poster Details

First Author: S.Shah UK

Co Author(s):    E. Berrow   S. Naroo   R. Gil Cazorla   P. Bilkhu   J. Wolffsohn        

Abstract Details

Purpose:

To assess visual performance and subjective experience of patients implanted with the SBL 3 bi-aspheric, multifocal intraocular lens (MIOL) 12 months post-implantation.

Setting:

Private clinic, Solihull, United Kingdom.

Methods:

Patients (average age 63.4 ± 12.3 years) were binocularly implanted with the SBL-3 MIOL (30 eyes). Twelve months post-implantation, assessment was made of: manifest refraction; uncorrected (UCDVA) and best corrected (BCDVA) distance visual acuity; uncorrected (UCNVA) and best corrected (BCNVA) near visual acuity; defocus curves - range +1.5 to -5.0 D in 0.5 Dioptres (D) in randomised increments and letters; Pelli-Robson contrast sensitivity (CS); halometry, using randomised letters and 45 degree increments; and patient’s satisfaction with unaided near vision, using the Near Acuity Visual Questionnaire (NAVQ).

Results:

Mean residual manifest refraction was +0.08 ± 0.42D. Mean UCDVA was +0.08 ± 0.17 logMAR. Mean UCNVA was J3, and BCNVA was J2. Mean CS was 1.65 ±0.14 log units. Halometry showed a glare profile of less than 1 degree of debilitating light scatter. Patients were very satisfied with their near vision according to NAVQ findings.

Conclusions:

The SBL-3 MIOL provides a good visual outcome at distance and near with minimal dysphotopsia at 12 months. Patients were very satisfied with their uncorrected near vision.

Financial Disclosure:

One or more of the authors receives consulting fees, retainer, or contract payments from a competing company

Back to Poster listing